Administration of Nω-nitro-l-arginine ameliorates portal-systemic shunting in portal-hypertensive rats
Open Access
- 30 November 1993
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 105 (5) , 1464-1470
- https://doi.org/10.1016/0016-5085(93)90152-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Role of Nitric Oxide in the Vascular Hyporesponsiveness to Methoxamine in Portal Hypertensive RatsHepatology, 1992
- Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxideHepatology, 1992
- Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertensionBritish Journal of Pharmacology, 1992
- Early chronic administration of propranolol reduces the severity of portal hypertension and portal-systemic shunts in conscious portal vein stenosed ratsJournal of Hepatology, 1991
- Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.Journal of Clinical Investigation, 1991
- Nitric oxide synthesis inhibitor prevents vasodilation by insulin-like growth factor IKidney International, 1991
- Portal hypertension ameliorates arterial hypertension in spontaneously hypertensive ratsJournal of Hepatology, 1989
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The Porto-Systemic Collateral Pattern in the RatEuropean Surgical Research, 1974